About this item
Product details
Glem-Lin from Nabiqasim is a advanced, dual-combination medication for the management of Type 2 Diabetes. Each tablet contains two active ingredients: Empagliflozin (10 mg), an SGLT2 inhibitor, and Linagliptin (5 mg), a DPP-4 inhibitor. This combination works through two distinct mechanisms to provide powerful blood sugar control, offering the convenience of two medications in a single tablet and helping to streamline treatment regimens. Dual-Mechanism Action: Combines two different classes of diabetes medication for enhanced glycemic control. Comprehensive Blood Sugar Management: Empagliflozin removes excess sugar through urine, while Linagliptin increases insulin release and decreases sugar production in the liver. Convenient Once-Daily Dosing: Simplifies the treatment regimen, improving adherence. Cardiovascular & Renal Benefits: Empagliflozin component has demonstrated benefits in reducing the risk of major cardiovascular events and slowing kidney disease progression. Weight-Neutral/Low Risk of Hypoglycemia: The Linagliptin component is associated with a low risk of causing low blood sugar (hypoglycemia) and is weight-neutral. Composition Each film coated tablet contains: Empagliflozin : 10 mg Linagliptin: 5 mg Suggested Usage As directed by the physician
- Medicines
- 14 Film Coated Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Nabiqasim
- SKU
- 08964003524104
- Variant
- 14 Film Coated Tablets
- Tags
- Empagliflozin, Linagliptin, Medicine
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
